Jung Mira 4
4 · Shuttle Pharmaceuticals Holdings, Inc. · Filed Oct 9, 2024
Insider Transaction Report
Form 4
Jung Mira
Chief Scientific Officer
Transactions
- Award
CLASS A COMMON STOCK
2024-05-01$11.28/sh−598$6,745→ 135,715 total
Footnotes (2)
- [F1]The Reporting Person received a grant of 1,791 restricted stock units ("RSUs") on May 1, 2023 (14,326 RSUs on a pre-reverse split basis), which RSUs are subject to vesting over a period of three years. The first vesting of 598 RSUs occurred on May 1, 2024.
- [F2]Consists of (i) 134,522 shares of common stock and (ii) 1,193 RSUs which remain subject to vesting. All share and RSU numbers reflect a 1-for-8 reverse stock split effected by the issuer on August 13, 2024.